Zhu Yifei, Yang Kai, Lin Jui-Ming, Ni Chunya, Zhang Yue, Li Zheng, Liu Qingmei, Zhou Yinghui, Lin Jinran, Wu Wenyu
Department of Dermatology, Shanghai Institute of Dermatology, Huashan Hospital, Fudan University, Shanghai, P.R. China.
Department of Dermatology, Jing'an District Central Hospital, Shanghai, P.R. China.
J Cosmet Dermatol. 2024 Dec;23(12):4213-4222. doi: 10.1111/jocd.16554. Epub 2024 Sep 19.
The robotic hair transplant technology, ARTAS, has a series of fine mechanical structure and an intelligent recognition system that allows it to independently select hair follicular units (FUs) and effectively harvest hair. After entering China in 2016, ARTAS has attracted the attention of hair transplant surgeons and hair loss patients given its advantages in a short learning curve and simple operation.
To compare the efficacy and safety between the ARTAS system and follicular unit excision (FUE) in the treatment of male androgenetic alopecia (AGA) and to further promote the improvement and upgrading of ARTAS technology concerning hair transplantation.
Thirteen Chinese male patients with Norwood-Hamilton II-IV AGA aged 25-35 years were enrolled in this study. The donor site of each patient was randomly divided into left and right regions, receiving ARTAS on one side and FUE on the other. Yield, transection, and discard rates of hair FUs from both sides were compared. Safety of the procedures in whole, as well as follow-up results were investigated and evaluated.
The total yield rate on the ARTAS side was lower than on the FUE side (82.05% vs. 90.03%, p > 0.05); the total discard rate on the ARTAS side was higher than on the FUE side (10.71% vs. 5.46%, p < 0.05); the total transection rate on the ARTAS side was lower than on the FUE side (13.17% vs. 13.96%, p > 0.05). No significant difference was found in patient satisfaction (efficacy), and no side effects or complications were detected during or after all surgeries.
The current iteration of Robotic hair transplant technology is effective and safe, and can be recommended for AGA hair transplantation surgery.
ARTAS机器人毛发移植技术拥有一系列精细的机械结构和智能识别系统，能够独立选取毛囊单位（FU）并有效提取毛发。2016年进入中国后，ARTAS因其学习曲线短、操作简便的优势，受到了毛发移植外科医生和脱发患者的关注。
比较ARTAS系统与毛囊单位提取术（FUE）治疗男性雄激素性脱发（AGA）的疗效和安全性，进一步推动ARTAS毛发移植技术的改进与升级。
本研究纳入13例年龄在25 - 35岁的中国男性Norwood - Hamilton II - IV级AGA患者。将每位患者的供体区随机分为左右两侧，一侧接受ARTAS治疗，另一侧接受FUE治疗。比较两侧毛发毛囊单位的提取率、横断率和丢弃率。对整个手术过程的安全性以及随访结果进行调查和评估。
ARTAS侧的总提取率低于FUE侧（82.05%对90.03%，p > 0.05）；ARTAS侧的总丢弃率高于FUE侧（10.71%对5.46%，p < 0.05）；ARTAS侧的总横断率低于FUE侧（13.17%对13.96%，p > 0.05）。患者满意度（疗效）方面未发现显著差异，所有手术过程中及术后均未检测到副作用或并发症。
当前版本的机器人毛发移植技术有效且安全，可推荐用于AGA毛发移植手术。
